Pemmaraju, Naveen
Utengen, Audun
Gupta, Vikas
Thompson, Michael A.
Lane, Andrew A.
Article History
First Online: 18 October 2018
Compliance with Ethical Standards
:
: Naveen Pemmaraju has received Honorarium/Consulting and/or Research/Grant & Clinical trial support from Novartis, LFB, Incyte, Stemline, Cellectis, Abbive, Affymetrix, Celgene, Samus, Plexxikon, Daiichi Sankyo, MustangBio, SagerStrong Foundation. Audun Utengen is a Co-founder of Symplur. Vikas Gupta received research grants from Novartis, Incyte, through his institution; served on scientific advisory board of Novartis and received honorarium from Novartis. Michael A. Thompson has been on Advisory Boards for: AIM Specialty Health. Andrew A. Lane has received funding from Stemline (research support and consulting), N-of-one (consulting).
: This article does not contain any studies with human or animal subjects performed by any of the authors.